Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Achillion Pharmaceuticals, Inc. (NQ: ACHN)
7.770 USD  +0.210 (+2.78%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Achillion Pharmaceuticals, Inc.
 
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Achillion to Present At the Cowen & Company 29th Annual Healthcare Conference
March 11, 2009
from GlobeNewswire News Releases
Achillion to Present At the 11th Annual BIO CEO & Investor Conference
February 05, 2009
from GlobeNewswire News Releases
ThinkPanmure Initiates Coverage on Achillon (ACHN) with a Buy
January 27, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4333045 for the full story. Read More
from StreetInsider.com News Articles
Achillion Announces Appointment of New Head of Business Development
January 07, 2009
from GlobeNewswire News Releases
Achillion Appoints Dr. Dennis Liotta to Board of Directors
December 18, 2008
Emory University Professor is Renowned Developer of HIV Drugs Read More
from GlobeNewswire News Releases
Achillion to Present At Lazard Capital Markets 5th Annual Healthcare Conference
November 17, 2008
from GlobeNewswire News Releases
Oppenheimer Downgrades Achillion Pharma (ACHN) to Perform
October 30, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4110438 for the full story. Read More
from StreetInsider.com News Articles
Achillion Reports Third Quarter 2008 Financial Results
October 28, 2008
from GlobeNewswire News Releases
Data From Achillion's Antibacterial and HIV Programs Presented At the 2008 ICAAC/IDSA Joint Meeting
October 27, 2008
from GlobeNewswire News Releases
Achillion Appoints Nicholas Simon to Board of Directors
August 20, 2008
from GlobeNewswire News Releases
Achillion Pharmaceuticals (ACHN) Reports Q2 Loss of $0.43
August 12, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3904769 for the full story. Read More
from StreetInsider.com News Articles
Achillion Reports Second Quarter 2008 Financial Results
August 12, 2008
Conference Call Today At 4:30PM ET Read More
from GlobeNewswire News Releases
Achillion to Present At Canaccord Adams Global Growth Conference
August 12, 2008
from GlobeNewswire News Releases
Achillion Pharmaceuticals (ACHN) In $41.5M Private Placement
August 06, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3883020 for the full story. Read More
from StreetInsider.com News Articles
Achillion Announces Private Placement Financing for up to $41.5 Million
August 06, 2008
from GlobeNewswire News Releases
Xmark Opportunity Partners Discloses 5.9% Stake in Achillion Pharmaceuticals (ACHN)
June 30, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3781892 for the full story. Read More
from StreetInsider.com News Articles
Achillion Pharmaceuticals (ACHN) Reports Positive Phase 2 Data for Elvucitabine
June 09, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3725472 for the full story. Read More
from StreetInsider.com News Articles
Achillion Announces Additional Positive Top-Line Phase 2 Data for Elvucitabine
June 09, 2008
Data At 48 Weeks Build Upon Previously Reported Antiviral Activity and Safety Profile Read More
from GlobeNewswire News Releases
Achillion Nominates ACH-1625 as Lead Candidate in Proprietary Program Targeting HCV Protease
June 04, 2008
Candidate Demonstrates Promising In Vivo Safety Profile and Potent In Vitro Activity Against Hepatitis C Read More
from GlobeNewswire News Releases
Achillion to Present At Needham Biotechnology Conference
May 23, 2008
from GlobeNewswire News Releases
Achillion Reports First Quarter 2008 Financial Results
May 07, 2008
from GlobeNewswire News Releases
Achillion and FOB Synthesis Announce Collaboration for the Development of Carbapenem Compounds
April 08, 2008
from GlobeNewswire News Releases
Achillion Appoints Gary E. Frashier to Board of Directors
April 02, 2008
from GlobeNewswire News Releases
Achillion Pharm (ACHN) Files To Offer $25M In Stock
March 17, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3463603 for the full story. Read More
from StreetInsider.com News Articles
Achillion to Present At Cowen Healthcare Conference
March 14, 2008
from GlobeNewswire News Releases
Achillion Pharmaceuticals (ACHN) Reports Q4 Loss of $0.44
February 27, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3408434 for the full story. Read More
from StreetInsider.com News Articles
Achillion Reports 2007 Fourth Quarter and Year-End Financial Results
February 27, 2008
from GlobeNewswire News Releases
Achillion to Present At the BIO CEO and Investor Conference
February 08, 2008
from GlobeNewswire News Releases
New Data for Achillion's Elvucitabine Demonstrate Drug's Safety, Efficacy and Suitability for Combination Therapy in HIV-Infected Patients
January 31, 2008
from GlobeNewswire News Releases
JMP Securities Starts Achillion Pharmaceuticals (ACHN) at Market Perform
January 29, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3301338 for the full story. Read More
from StreetInsider.com News Articles
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here